Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGreggs Regulatory News (GRG)

Share Price Information for Greggs (GRG)

Share Price is delayed by 15 minutes
Get Live Data
1,648.00    -13.00 (-0.78%)
Bid:
1,639.00
Ask:
1,644.00
Spread: 5.00 (0.305%)
Market Cap: £1.68b
GRG Live PriceLast checked at - London Stock Exchange

Intraday Greggs Share Chart

Director/PDMR Shareholding

11 Nov 2009 16:42

RNS Number : 3703C
Greggs PLC
11 November 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING

MANAGERIAL RESPONSIBILITYΒ ANDΒ CONNECTED PERSONS

1.Β Name of theΒ issuer

GREGGSΒ PLC

2. State whether the notification relates to

(i) aΒ transaction notified in accordanceΒ withΒ DTRΒ 3.1.2R;

(ii) a disclosure made inΒ accordance withΒ LR 9.8.6R(1); or

(iii)Β a disclosure made in accordance with section 793 of the Companies Act (2006)

(i)

3. Name ofΒ person discharging managerial responsibilities/director

KENNEDY McMEIKAN

4. State whether notification relates to aΒ personΒ connected with aΒ person discharging

managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

N/A

5. Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficialΒ interest

3

6. Description ofΒ sharesΒ (includingΒ class),Β debentures or derivatives or financialΒ instruments relating toΒ shares

ORDINARYΒ Β£0.02

7. Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

KENNEDY McMEIKAN

8 State the nature of the transactionΒ 

PURCHASEΒ OF SHARES

9. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

4,700

10. Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken intoΒ account when calculating percentage)

0.005%

11. Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

N/A

12. Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken intoΒ account when calculating percentage)

N/A

13. Price perΒ shareΒ or value of transactionΒ 

Β£20,034.69 TOTAL VALUE OF TRANSACTION

14. Date and place of transaction

11Β NOVEMBER 2009

15. Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken intoΒ account when calculating percentage)

57,860Β SHARESΒ (0.06%)

16. Date issuer informed of transactionΒ 

11Β November 2009Β 

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes:

17 Date of grantΒ 

N/A

18. Period during which or date on which exercisable

N/A

19. Total amount paid (if any) for grant of theΒ option

N/A

20. Description ofΒ sharesΒ or debentures involvedΒ (classΒ and number)

N/A

21. Exercise price (if fixed at time of grant) orΒ indication that price is to be fixed at the timeΒ of exercise

N/A

22. Total number ofΒ sharesΒ or debentures overΒ which options held following notification

N/A

23. Any additional informationΒ 

N/A

24. Name of contact and telephone number forΒ queries

NameΒ of authorised officialΒ ofΒ issuerΒ responsible for making notification

ANDREW DAVISON

COMPANY SECRETARY

GREGGSΒ PLCΒ 

TEL: 0191 211 7950

Date 11Β NOVEMBERΒ 2009

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSBLBDBBSBGGCB
Date   Source Headline
24th Jun 202610:55 amRNSDirector/PDMR Shareholding
22nd Jun 202612:10 pmRNSDirector/PDMR Shareholding
22nd Jun 202612:10 pmRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSAppointment of Non-Executive Director
27th May 202611:59 amRNSDirector/PDMR Shareholding - Amendment
19th May 20263:32 pmRNSDirector/PDMR Shareholding
13th May 20263:40 pmRNSResult of AGM
12th May 20267:00 amRNSTrading Update
30th Apr 20267:00 amRNSNotice of Trading Update
13th Apr 20267:15 amRNSAnnual Financial Report
13th Apr 20267:00 amRNS-RGreggs Publishes Sustainability Report For 2025
3rd Mar 20267:00 amRNSPreliminary Results
10th Feb 20267:00 amRNSNotice of Preliminary Results
15th Jan 20262:57 pmRNSHolding(s) in Company
8th Jan 20267:00 amRNSQ4 Trading Update
18th Dec 20257:00 amRNSNotice of Trading Update
16th Dec 20257:00 amRNSAppointment of Non-Executive Director
28th Nov 20252:45 pmRNSHolding(s) in Company
19th Nov 20254:06 pmRNSBoard Update
5th Nov 20253:29 pmRNSDirector/PDMR Shareholding
5th Nov 20253:25 pmRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSQ3 Trading Update
15th Sep 20257:00 amRNSNotice of Trading Update
28th Aug 20257:00 amRNSBoard Update
20th Aug 202511:18 amRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSInterim Results
29th Jul 20257:00 amRNSAppointment of Non-Executive Director
15th Jul 20257:00 amRNSNotice of Interim Results
2nd Jul 20257:00 amRNSFIRST HALF 2025 TRADING UPDATE
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:29 pmRNSDirector/PDMR Shareholding
17th Jun 202512:27 pmRNSDirector/PDMR Shareholding
17th Jun 202511:04 amRNSDirector/PDMR Shareholding
21st May 20253:36 pmRNSResult of AGM
20th May 20257:00 amRNSTrading Update
25th Apr 20257:00 amRNSNotice of Trading Update
16th Apr 20259:43 amRNSAnnual Financial Report
16th Apr 20257:15 amRNSAnnual Financial Report
16th Apr 20257:00 amRNS-RGreggs Publishes Sustainability Report For 2024
26th Mar 20251:05 pmRNSDirector/PDMR Shareholding
26th Mar 20251:04 pmRNSDirector/PDMR Shareholding
26th Mar 202510:17 amRNSDirector/PDMR Shareholding
26th Mar 202510:14 amRNSDirector/PDMR Shareholding
4th Mar 20257:00 amRNSPreliminary Results
6th Feb 20257:00 amRNSNotice of Preliminary Results
13th Jan 20253:15 pmRNSDirector/PDMR Shareholding
9th Jan 20257:00 amRNSQ4 Trading Update
12th Dec 20247:00 amRNSNotice of Trading Update
24th Oct 20242:04 pmRNSDirector/PDMR Shareholding
10th Oct 202410:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.